A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of 223Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases

By S. J. Chittenden, C. Hindorf, C. C. Parker, V. J. Lewington, B. E. Pratt, B. Johnson and G. D. Flux

Publisher: Society of Nuclear Medicine

Year: 2015

DOI identifier: 10.2967/jnumed.115.157123

OAI identifier:

Provided by: MUCC (Crossref)

Download PDF:
_{Sorry, we are unable to provide the full text but you may find it at the
following location(s):}

http://jnm.snmjournals.org/con... (external link)